PROCEPT BioRobotics Corp financial data

Symbol
PRCT on Nasdaq
Location
150 Baytech Drive, San Jose, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 2, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 790 % -0.02%
Quick Ratio 106 % +2.96%
Debt-to-equity 40.3 % -16.3%
Return On Equity -28.1 % +32.1%
Return On Assets -20 % +28.3%
Operating Margin -38.7 % +44.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 55.3M shares +7.59%
Common Stock, Shares, Outstanding 55.3M shares +7.56%
Entity Public Float 3.1B USD +121%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 54.9M shares +7.66%
Weighted Average Number of Shares Outstanding, Diluted 54.9M shares +7.66%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 249M USD +59.4%
Cost of Revenue 92.9M USD +27.7%
Research and Development Expense 65.6M USD +29.2%
Operating Income (Loss) -96.4M USD +11.1%
Net Income (Loss) Attributable to Parent -90.2M USD +12.7%
Earnings Per Share, Basic -2 USD/shares +20.3%
Earnings Per Share, Diluted -2 USD/shares +20.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 316M USD +40.2%
Accounts Receivable, after Allowance for Credit Loss, Current 79.3M USD +41.3%
Inventory, Net 62.3M USD +49.8%
Assets, Current 466M USD +41.5%
Property, Plant and Equipment, Net 28.1M USD -1.27%
Operating Lease, Right-of-Use Asset 18.6M USD -6.47%
Other Assets, Noncurrent 2.95M USD +154%
Assets 519M USD +35.6%
Accounts Payable, Current 14.8M USD +47%
Contract with Customer, Liability, Current 9.8M USD +67.2%
Liabilities, Current 52.1M USD +34.7%
Contract with Customer, Liability, Noncurrent 517K USD
Operating Lease, Liability, Noncurrent 26.3M USD -7%
Other Liabilities, Noncurrent 324K USD -37.3%
Liabilities 130M USD +9.56%
Accumulated Other Comprehensive Income (Loss), Net of Tax 223K USD +97.3%
Retained Earnings (Accumulated Deficit) -571M USD -18.8%
Stockholders' Equity Attributable to Parent 389M USD +47.4%
Liabilities and Equity 519M USD +35.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17M USD +47.4%
Net Cash Provided by (Used in) Financing Activities 1.3M USD -49.8%
Net Cash Provided by (Used in) Investing Activities -1.84M USD +5.65%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 55.3M shares +7.56%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -17.5M USD +44.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 319M USD +39.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 885K USD -11.9%
Deferred Tax Assets, Valuation Allowance 156M USD +28.6%
Deferred Tax Assets, Gross 161M USD +27.2%
Operating Lease, Liability 28.3M USD -5.67%
Payments to Acquire Property, Plant, and Equipment 1.84M USD -5.65%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -90.1M USD +12.8%
Lessee, Operating Lease, Liability, to be Paid 39.7M USD -9.57%
Property, Plant and Equipment, Gross 37.3M USD +12.1%
Operating Lease, Liability, Current 1.98M USD +16.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.81M USD +8.63%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.43M USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11.4M USD -18%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.95M USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 96.5M USD +20.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 4.72M USD +39.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.1M USD +3.01%
Additional Paid in Capital 960M USD +28.9%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.48M USD +24.6%
Deferred Tax Assets, Net of Valuation Allowance 4.66M USD -6.09%
Share-based Payment Arrangement, Expense 35.7M USD +64.7%
Interest Expense 4.15M USD -10.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%